Article Text

other Versions

PDF
Obesity and comorbidity are independently associated with a failure to achieve remission in patients with established rheumatoid arthritis
  1. Nicolas Ellerby1,
  2. Derek L Mattey1,2,
  3. Jonathan Packham1,
  4. Peter Dawes1,
  5. Samantha L Hider1,3
  1. 1Haywood Rheumatology Centre, Haywood Hospital, Stoke on Trent, UK
  2. 2Institute of Science and Technology in Medicine, Keele University, Keele, Staffordshire, UK
  3. 3Arthritis Research UK Primary Care Centre, Keele University, Keele, Staffordshire, UK
  1. Correspondence to Dr SL Hider, 1-Haywood rheumatology centre, Haywood Hospital, High Lane, Stoke on Trent ST6 7AG, UK; s.hider@.keele.ac.uk

Statistics from Altmetric.com

We read with interest the recent paper by Sandberg et al1 highlighting the negative impact of obesity on disease remission in a cohort of patients with early rheumatoid arthritis (RA).

We have investigated the impact of both obesity and comorbidity on disease remission in an established RA cohort. Data were collected prospectively between 2003 and 2011 from the Haywood Hospital, North Staffordshire, UK. Patients fulfilled the 1987 American College of Rheumatology criteria for RA,2 had been followed up for 3 years and were taking conventional (non-biologic disease-modifying antirheumatic drugs (DMARDs)) at baseline. Participants underwent an annual standardised research assessment, separate to their routine clinical care, including demographics, body mass index (BMI) and disease …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles